PTEN and hepatocellular carcinoma: Conversely, miR-221/222 downregulates PTEN expression by directly targeting PTEN mRNA in diseases such as NSCLC, hepatocellular carcinoma (HCC), and TNF-related apoptosis-inducing ligand (TRAIL)-induced cell death [43].